98 related articles for article (PubMed ID: 25779376)
21. A western blot assay for detecting mutant nucleophosmin (NPM1) proteins in acute myeloid leukaemia.
Martelli MP; Manes N; Liso A; Pettirossi V; Verducci Galletti B; Bigerna B; Pucciarini A; De Marco MF; Pallotta MT; Bolli N; Sborgia M; di Raimondo F; Fabbiano F; Meloni G; Specchia G; Martelli MF; Falini B
Leukemia; 2008 Dec; 22(12):2285-8. PubMed ID: 18563173
[No Abstract] [Full Text] [Related]
22. Is the association of "cup-like" nuclei with mutation of the NPM1 gene in acute myeloid leukemia clinically useful?
Bennett JM; Pryor J; Laughlin TS; Rothberg PG; Burack WR
Am J Clin Pathol; 2010 Oct; 134(4):648-52. PubMed ID: 20855646
[TBL] [Abstract][Full Text] [Related]
23. DNA damage corrects the aberrant cytoplasmic localisation of nucleophosmin in NPM1 mutated acute myeloid leukaemia.
Bailey GD; Qutob HMH; Akhtar A; Russell NH; Seedhouse CH
Br J Haematol; 2019 Jul; 186(2):343-347. PubMed ID: 30836427
[No Abstract] [Full Text] [Related]
24. A novel mechanism of NPM1 cytoplasmic localization in acute myeloid leukemia: the recurrent gene fusion NPM1-HAUS1.
Campregher PV; de Oliveira Pereira W; Lisboa B; Puga R; Deolinda ER; Helman R; Marti LC; Guerra JC; Manola KN; Petroni RC; Bezerra AM; Costa FF; Hamerschlak N; de Souza Santos FP
Haematologica; 2016 Jul; 101(7):e287-90. PubMed ID: 27036161
[No Abstract] [Full Text] [Related]
25. FLT3 and NPM1 mutations in a cohort of AML patients and detection of a novel mutation in tyrosine kinase domain of FLT3 gene from Western India.
Ghosh K; Swaminathan S; Madkaikar M; Gupta M; Kerketta L; Vundinti B
Ann Hematol; 2012 Nov; 91(11):1703-12. PubMed ID: 22733614
[TBL] [Abstract][Full Text] [Related]
26. [Immunohistochemical demonstration of mutant nucleophosmin in acute myeloid leukemia: biological and clinical features related to NPMc expression].
Bedekovics J; Rejto L; Telek B; Udvardy M; Ujfalusi A; Oláh E; Hevessy Z; Kappelmayer J; Kajtár B; Méhes G
Orv Hetil; 2009 May; 150(22):1031-5. PubMed ID: 19465351
[TBL] [Abstract][Full Text] [Related]
27. Monitoring of minimal residual disease in acute myeloid leukemia with frequent and rare patient-specific NPM1 mutations.
Dvorakova D; Racil Z; Jeziskova I; Palasek I; Protivankova M; Lengerova M; Razga F; Mayer J
Am J Hematol; 2010 Dec; 85(12):926-9. PubMed ID: 20981679
[TBL] [Abstract][Full Text] [Related]
28. Flow cytometric identification of acute myeloid leukemia with limited differentiation and NPM1 type A mutation: a new biologically defined entity.
Kern W; Haferlach C; Bacher U; Haferlach T; Schnittger S
Leukemia; 2009 Jul; 23(7):1361-4. PubMed ID: 19369962
[No Abstract] [Full Text] [Related]
29. Detection of CD34, TdT, CD56, CD2, CD4, and CD14 by flow cytometry is associated with NPM1 and FLT3 mutation status in cytogenetically normal acute myeloid leukemia.
Dalal BI; Mansoor S; Manna M; Pi S; Sauro GD; Hogge DE
Clin Lymphoma Myeloma Leuk; 2012 Aug; 12(4):274-9. PubMed ID: 22481022
[TBL] [Abstract][Full Text] [Related]
30. Late relapse of acute myeloid leukemia with mutated NPM1 after eight years: evidence of NPM1 mutation stability.
Meloni G; Mancini M; Gianfelici V; Martelli MP; Foa R; Falini B
Haematologica; 2009 Feb; 94(2):298-300. PubMed ID: 19181793
[No Abstract] [Full Text] [Related]
31. Venetoclax and arsenic showed synergistic anti-leukemia activity in vitro and in vivo for acute myeloid leukemia with the NPM1 mutation.
Zhu HH; Qian JJ; Sun WJ; You LS; Wang QQ; Naranmandura H; Jin J
Am J Hematol; 2020 Mar; 95(3):E55-E57. PubMed ID: 31907961
[No Abstract] [Full Text] [Related]
32. Role of nucleophosmin in acute myeloid leukemia.
Meani N; Alcalay M
Expert Rev Anticancer Ther; 2009 Sep; 9(9):1283-94. PubMed ID: 19761432
[TBL] [Abstract][Full Text] [Related]
33. Simultaneous occurrence of acute myeloid leukaemia with mutated nucleophosmin (NPM1) in the same family.
Cazzaniga G; Lo Nigro L; Cifola I; Milone G; Schnittger S; Haferlach T; Mirabile E; Costantino F; Martelli MP; Mastrodicasa E; Di Raimondo F; Aversa F; Biondi A; Falini B
Leukemia; 2009 Jan; 23(1):199-203. PubMed ID: 18596743
[No Abstract] [Full Text] [Related]
34. Monoallelic CEBPA mutations in normal karyotype acute myeloid leukemia: independent favorable prognostic factor within NPM1 mutated patients.
Dufour A; Schneider F; Hoster E; Benthaus T; Ksienzyk B; Schneider S; Kakadia PM; Sauerland MC; Berdel WE; Büchner T; Wörmann B; Braess J; Subklewe M; Hiddemann W; Bohlander SK; Spiekermann K;
Ann Hematol; 2012 Jul; 91(7):1051-63. PubMed ID: 22362118
[TBL] [Abstract][Full Text] [Related]
35. Reply to: 'Flow cytometric identification of acute myeloid leukemia with limited differentiation and NPM1 type A mutation: a new biologically defined entity' by Kern et al.
Oelschlaegel U; Mohr B; Schaich M; Kroschinsky F; Parmentier S; Bornhäuser M; Ehninger G; Thiede C
Leukemia; 2011 May; 25(5):895-7. PubMed ID: 21331074
[No Abstract] [Full Text] [Related]
36. Downregulation of MEIS1 impairs long-term expansion of CD34+ NPM1-mutated acute myeloid leukemia cells.
Woolthuis CM; Han L; Verkaik-Schakel RN; van Gosliga D; Kluin PM; Vellenga E; Schuringa JJ; Huls G
Leukemia; 2012 Apr; 26(4):848-53. PubMed ID: 21986840
[No Abstract] [Full Text] [Related]
37. NPM1-mutated acute myeloid leukemia of monocytic or myeloid origin exhibit distinct immunophenotypes.
Liu YR; Zhu HH; Ruan GR; Qin YZ; Shi HX; Lai YY; Chang Y; Wang YZ; Lu D; Hao L; Li JL; Li LD; Jiang B; Huang XJ
Leuk Res; 2013 Jul; 37(7):737-41. PubMed ID: 23601747
[TBL] [Abstract][Full Text] [Related]
38. Lack of noncanonical RAS mutations in cytogenetically normal acute myeloid leukemia.
Reuter CW; Krauter J; Onono FO; Bunke T; Damm F; Thol F; Wagner K; Göhring G; Schlegelberger B; Heuser M; Ganser A; Morgan MA
Ann Hematol; 2014 Jun; 93(6):977-82. PubMed ID: 24737308
[TBL] [Abstract][Full Text] [Related]
39. NPM1-mutated acute myeloid leukaemia occurring in JAK2-V617F+ primary myelofibrosis: de-novo origin?
Pasqualucci L; Li S; Meloni G; Schnittger S; Gattenlohner S; Liso A; Di Ianni M; Martelli MP; Pescarmona E; Foa R; Haferlach T; Skoda RC; Falini B
Leukemia; 2008 Jul; 22(7):1459-63. PubMed ID: 18200037
[No Abstract] [Full Text] [Related]
40. miR-21 is overexpressed in NPM1-mutant acute myeloid leukemias.
Riccioni R; Lulli V; Castelli G; Biffoni M; Tiberio R; Pelosi E; Lo-Coco F; Testa U
Leuk Res; 2015 Feb; 39(2):221-8. PubMed ID: 25543261
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
